Institutional members access full text with Ovid®

Share this article on:

Healing of a Segmental Defect in the Rat Femur with Use of an Extract from a Cultured Human Osteosarcoma Cell-Line (Saos-2). A Preliminary Report*

HUNT, THOMAS R. M.D.†; SCHWAPPACH, JOHN R. M.D.‡; ANDERSON, H. CLARKE M.D.§, KANSAS CITY, KANSAS

Journal of Bone & Joint Surgery - American Volume: January 1996 - Volume 78 - Issue 1 - p 41–8
Article

Devitalized extracts from cultured human osteosarcoma cells (Saos-2) can induce ectopic bone formation. The ability of an extract from Saos-2 cells to stimulate healing of an operatively created four-millimeter defect in the femoral diaphyses of rats was compared with that of collagen and that of autogenous bone graft. Forty adult rats were randomized into four groups of ten each. In Group 1 (controls), no material was placed in the defect; in Group 2, the defect was filled with pure bovine collagen; in Group 3, it was filled with autogenous graft obtained by morseling of the resected segment of the femur; and in Group 4, it was filled with ten milligrams of extract from Saos-2 cells that was mixed with an equal amount of bovine collagen. Five rats from each group were killed at four weeks and the remaining five, at eight weeks. Each femoral defect was analyzed radiographically and histologically for osseous healing. There was no evidence of healing at either four or eight weeks in Groups 1 and 2. Although there was some new-bone formation in Group 3, none of the defects had united at eight weeks. There was early, almost complete union in all five four-week specimens in Group 4 and complete healing of the defect in four of the five rats assessed at eight weeks. The Saos-2 cell extract was found to be the most effective agent, promoting union by mature lamellar bone within eight weeks. CLINICAL RELEVANCE: Potential clinical applications of Saos-2-cell bone-inducing extract include the promotion of bone growth in fracture non-unions, in large operatively created defects, and in spinal arthrodeses. It is possible that a bone-inducing extract could enhance osteointegration of porous prosthetic implants.

†Department of Orthopaedic Surgery, Virginia Mason Medical Center, Seattle, Washington 98111.

‡Department of Orthopaedic Surgery, University of Colorado Medical Center, 4701 East 9th Avenue, Denver, Colorado 80262.

§Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, Kansas 66160-7410.

Copyright 1996 by The Journal of Bone and Joint Surgery, Incorporated
You currently do not have access to this article

To access this article: